PMID- 28477343 OWN - NLM STAT- MEDLINE DCOM- 20180926 LR - 20181202 IS - 1099-1611 (Electronic) IS - 1057-9249 (Linking) VI - 26 IP - 12 DP - 2017 Dec TI - Mindfulness-based cognitive therapy (MBCT) is cost-effective compared to a wait-list control for persistent pain in women treated for primary breast cancer-Results from a randomized controlled trial. PG - 2208-2214 LID - 10.1002/pon.4450 [doi] AB - OBJECTIVE: To investigate the cost-effectiveness of mindfulness-based cognitive therapy (MBCT) compared to a wait-list control group for pain in women treated for breast cancer. METHODS: A total of 129 women were randomly allocated to MBCT or a wait-list control group. The primary outcome was the minimal clinically important difference (MCID) on pain intensity (>/=2 point reduction on an 11-point Numeric Rating Scale). Analyses were conducted from the health care system perspective and included data on health care utilization and pain medication retrieved from national registries for the period from baseline (T1) to 6 months postintervention (T4). Bootstrap simulations were used to estimate confidence intervals for the incremental cost and effect measures, and cost-effectiveness acceptability curves. In sensitivity analyses, we replaced dropouts with last-observation-carried-forward and tested consequences of higher costs of the intervention. RESULTS: The intervention cost was 240euro per participant. The average total cost from T1 to T4 in the MBCT group was 1706euro compared with 2436euro in the control group (mean difference: 729euro, P = .07). More women in the MBCT group (N:19/36; 52.8%) than in the control group (N:14/48; 29.2%) achieved an MCID in pain intensity (OR=2.71, P = .03). The MBCT was cost-effective with a probability of 85% with a value of an additional women achieving MCID set to zero remained cost-effective with a probability of 70% to 82% when smaller effect and higher MBCT costs were assumed. CONCLUSIONS: Our results suggest that MBCT is a cost-effective pain intervention for women treated for breast cancer. Future studies could include utility measures, indirect costs, and active control groups to increase the generalizability and pragmatic value of the results. CI - Copyright (c) 2017 John Wiley & Sons, Ltd. FAU - Johannsen, M AU - Johannsen M AUID- ORCID: 0000-0002-7849-7534 AD - Unit for Psychooncology and Health Psychology, Dept. of Oncology, Aarhus University Hospital and Dept of Psychology, Aarhus University, Aarhus, Denmark. AD - Centre for Integrated Registry-Based Research (CIRRAU), Aarhus University, Aarhus, Denmark. FAU - Sorensen, J AU - Sorensen J AD - Centre for Health Economics Research, Dept of Public Health, University of Southern Denmark, Odense C, Denmark. AD - Health Outcome Research Centre, Royal College of Surgeons in Ireland, Dublin 2, Ireland. FAU - O'Connor, M AU - O'Connor M AD - Unit for Psychooncology and Health Psychology, Dept. of Oncology, Aarhus University Hospital and Dept of Psychology, Aarhus University, Aarhus, Denmark. FAU - Jensen, A B AU - Jensen AB AD - Dept. of Oncology, Aarhus University Hospital, Aarhus, Denmark. FAU - Zachariae, R AU - Zachariae R AD - Unit for Psychooncology and Health Psychology, Dept. of Oncology, Aarhus University Hospital and Dept of Psychology, Aarhus University, Aarhus, Denmark. LA - eng PT - Journal Article DEP - 20170531 PL - England TA - Psychooncology JT - Psycho-oncology JID - 9214524 SB - IM MH - Adult MH - Breast Neoplasms/psychology/*therapy MH - Cancer Pain/rehabilitation/*therapy MH - Cognitive Behavioral Therapy/*economics/methods MH - Cost-Benefit Analysis MH - Female MH - Humans MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Mindfulness/*economics/methods MH - Pain Management MH - Psychotherapy, Group MH - Randomized Controlled Trials as Topic MH - Treatment Outcome MH - *Waiting Lists OTO - NOTNLM OT - cancer OT - cost analyses OT - cost-effectiveness OT - mindfulness OT - mindfulness-based intervention OT - oncology OT - pain OT - pain interventions OT - pain rehabilitation OT - persistent pain EDAT- 2017/05/10 06:00 MHDA- 2018/09/27 06:00 CRDT- 2017/05/07 06:00 PHST- 2016/11/11 00:00 [received] PHST- 2017/02/27 00:00 [revised] PHST- 2017/04/27 00:00 [accepted] PHST- 2017/05/10 06:00 [pubmed] PHST- 2018/09/27 06:00 [medline] PHST- 2017/05/07 06:00 [entrez] AID - 10.1002/pon.4450 [doi] PST - ppublish SO - Psychooncology. 2017 Dec;26(12):2208-2214. doi: 10.1002/pon.4450. Epub 2017 May 31.